Skip to main content
SpringerLink
Log in

Prime Solutions for Extracorporeal Circulation

  • Chapter
On Bypass

Part of the book series: Current Cardiac Surgery ((CCS))

  • 2850 Accesses

Abstract

Various crystalloid and colloidal solutions, as well as various volumes of these solutions, are used to prime the cardiopulmonary bypass (CPB) circuit. Several institutions have developed “standard” priming solutions and volumes for all adult patients, whereas other institutions base their primes on body weight and body surface area. The significant variability in both CPB prime content and volume is primarily caused by the lack of data from well-designed trials evaluating differences in patient outcomes. Several studies have been performed examining intermediate outcomes, such as biochemical markers, and special concerns, including transfusion requirements; however, much of the available data are inconsistent and inconclusive.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Prien T, Thulig B, Wusten R, Schoofs J, Weyand M, Lawin P. [Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses]. Zentralbl Chir 1993; 118:257–263; discussion 264–266.

    CAS  PubMed  Google Scholar 

  2. Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P. Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 1990;2:317–323.

    Article  CAS  PubMed  Google Scholar 

  3. Tollofsrud S, Svennevig JL, Breivik H, et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer’s acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand 1995;39:671–677.

    Article  CAS  PubMed  Google Scholar 

  4. Foglia RP, Lazar HL, Steed DL, et al. Iatrogenic myocardial edema with crystalloid primes: effects on left ventricular compliance, performance, and perfusion. Surg Forum 1978;29:312–315.

    CAS  PubMed  Google Scholar 

  5. Hoeft A, Korb H, Mehlhorn U, Stephan H, Sonntag H. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth 1991;66:73–80.

    Article  CAS  PubMed  Google Scholar 

  6. Mehlhorn U, Allen SJ, Davis KL, Geissler HJ, Warters RD, Rainer de Vivie E. Increasing the colloid osmotic pressure of cardiopulmonary bypass prime and normothermic blood cardioplegia minimizes myocardial oedema and prevents cardiac dysfunction. Cardiovasc Surg 1998;6:274–281.

    Article  CAS  PubMed  Google Scholar 

  7. Geissler HJ, Allen SJ. Myocardial fluid balance: pathophysiology and clinical implications. Thorac Cardiovasc Surg 1998;46Suppl 2:242–245; discussion 246–247.

    Article  PubMed  Google Scholar 

  8. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 1992;74:219–225.

    CAS  PubMed  Google Scholar 

  9. Kuitunen A, Hynynen M, Salmenpera M, et al. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand 1993;37:652–658.

    Article  CAS  PubMed  Google Scholar 

  10. Cope JT, Banks D, Mauney MC, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg 1997;63:78–82; discussion 82–83.

    Article  CAS  PubMed  Google Scholar 

  11. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004;98:291–297.

    Article  CAS  PubMed  Google Scholar 

  12. Gravlee D, Kurusz, Utley. Cardiopulmonar Bypass: Principles and Practice. Second Edition. Lippincott Williams, Philadelphia, 2000.

    Google Scholar 

  13. Sade RM, Stroud MR, Crawford FA, Jr., Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer’s solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985;89:713–722.

    CAS  PubMed  Google Scholar 

  14. Lumb PD. A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass. Ann Surg 1987;206:210–213

    Article  CAS  PubMed  Google Scholar 

  15. Canver CC, Nichols RD. Use of intraoperative hetastarch priming during coronary bypass. Chest 2000;118:1616–1620.

    Article  CAS  PubMed  Google Scholar 

  16. Herwaldt LA, Swartzendruber SK, Edmond MB, et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 1998;19:9–16.

    Article  CAS  PubMed  Google Scholar 

  17. Kovalik SG, Ledgerwood AM, Lucas CE, Higgins RF. The cardiac effect of altered calcium homeostasis after albumin resuscitation. J Trauma 1981;21: 275–279.

    Article  CAS  PubMed  Google Scholar 

  18. Scott DA, Hore PJ, Cannata J, Masson K, Treagus B, Mullaly J. A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery. Perfusion 1995;10:415–424.

    Article  CAS  PubMed  Google Scholar 

  19. Bennett-Guerrero E, Frumento RJ, Mets B, Manspeizer H, Hirsh A. Impact of normal saline based versus balanced salt intravenous fluid replacement on clinical outcomes: a randomized blinded clinical trial. Anesthesiology 2001;92:A106.

    Google Scholar 

  20. Gore DC, Dalton JM, Gehr TW. Colloid infusions reduce glomerular filtration in resuscitated burn victims. J Trauma 1996;40:356–360.

    Article  CAS  PubMed  Google Scholar 

  21. Lucas CE. Renal considerations in the injured patient. Surg Clin North Am 1982;62:133–148.

    CAS  PubMed  Google Scholar 

  22. Fisher AR. The incidence and cause of emergency oxygenator changeovers. Perfusion 1999;14:207–212.

    CAS  PubMed  Google Scholar 

  23. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth 2004;18:429–437.

    Article  CAS  PubMed  Google Scholar 

  24. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983;74:540–544.

    Article  CAS  PubMed  Google Scholar 

  25. Metz S, Keats AS. Benefits of a glucose-containing priming solution for cardiopulmonary bypass. Anesth Analg 1991;72:428–434.

    CAS  PubMed  Google Scholar 

  26. Newland RF, Baker RA, Mazzone AL, Ottens J, Sanderson AJ, Moubarak JR. Removal of glucose from the cardiopulmonary bypass prime: a prospective clinical audit. J Extra Corpor Technol 2004;36:240–244.

    CAS  PubMed  Google Scholar 

  27. Stanic M, Sindjelic R, Neskovic V, Davidovic L, Lotina S. [Renal protection during surgical procedures on the infrarenal aorta]. Srp Arh Celok Lek 2002; 130:168–172.

    Article  PubMed  Google Scholar 

  28. Carcoana OV, Mathew JP, Davis E, et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial. Anesth Analg 2003;97:1222–1229.

    Article  CAS  PubMed  Google Scholar 

  29. Ip-Yam PC, Murphy S, Baines M, Fox MA, Desmond MJ, Innes PA. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg 1994;78:842–847.

    Article  CAS  PubMed  Google Scholar 

  30. Maquelin KN, Nieuwland R, Lentjes EG, Boing AN, Mochtar B, Eijsman L, Sturk A: Aprotinin administration in the pericardial cavity does not prevent platelet activation. J Thorac Cardiovasc Surg 2000;120:552–557.

    Article  CAS  PubMed  Google Scholar 

  31. Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double-blind, placebocontrolled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995;92:2236–2244.

    CAS  PubMed  Google Scholar 

  32. Poullis M, Manning R, Laffan M, Haskard DO, Taylor KM, Landis RC. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg 2000; 120:370–378.

    Article  CAS  PubMed  Google Scholar 

  33. Schonberger JP, Everts PA, Ercan H, et al. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. Ann Thorac Surg 1992;54:1172–1176.

    Article  CAS  PubMed  Google Scholar 

  34. Liam BL, Plochl W, Cook DJ, Orszulak TA, Daly RC. Hemodilution and whole body oxygen balance during normothermic cardiopulmonary bypass in dogs. J Thorac Cardiovasc Surg 1998;115:1203–1208.

    Article  CAS  PubMed  Google Scholar 

  35. Osawa H, Yoshii S, Abraham SJ, et al. Critical values of hematocrit and mixed venous oxygen saturation as parameters for a safe cardiopulmonary bypass. Jpn J Thorac Cardiovasc Surg 2004;52:49–56.

    Article  PubMed  Google Scholar 

  36. Shapira OM, Aldea GS, Treanor PR, et al. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg 1998;65:724–730.

    Article  CAS  PubMed  Google Scholar 

  37. Rosengart TK, DeBois W, O’Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg 1998;115:426–438; discussion 438–439.

    Article  CAS  PubMed  Google Scholar 

  38. Liskaser FJ, Bellomo R, Hayhoe M, et al. Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology 2000;93:1170–1173.

    Article  CAS  PubMed  Google Scholar 

  39. Eising GP, Pfauder M, Niemeyer M, et al. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery? Ann Thorac Surg 2003;75:23–27.

    Article  PubMed  Google Scholar 

  40. Groom RC, Akl BF, Albus R, Lefrak EA. Pediatric cardiopulmonary bypass: a review of current practice. Int Anesthesiol Clin 1996;34:141–163.

    Article  CAS  PubMed  Google Scholar 

  41. Riegger LQ, Voepel-Lewis T, Kulik TJ, et al. Albumin versus crystalloid prime solution for cardiopulmonary bypass in young children. Crit Care Med 2002; 30:2649–2654.

    Article  CAS  PubMed  Google Scholar 

  42. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992;54:541–546.

    CAS  PubMed  Google Scholar 

  43. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845–857.

    CAS  PubMed  Google Scholar 

  44. Petaja J, Lundstrom U, Leijala M, Peltola K, Siimes MA. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995;109:524–529.

    Article  CAS  PubMed  Google Scholar 

  45. Shoemaker WC, Wo CC. Circulatory effects of whole blood, packed red cells albumin, starch, and crystalloids in resuscitation of shock and acute critical illness. Vox Sang 1998;74Suppl 2:69–74.

    PubMed  Google Scholar 

  46. Ramsey G, Sherman LA. Transfusion therapy in solid organ transplantation. Hematol Oncol Clin North Am 1994;8:1117–1129.

    CAS  PubMed  Google Scholar 

  47. Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med 2004; 351:1635–1644.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Duke University Medical Center, Durham, NC

    Robert J. Frumento MS, MPH & Elliott Bennett-Guerrero MD

Authors
  1. Robert J. Frumento MS, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elliott Bennett-Guerrero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiothoracic Surgery Clinical Perfusion, New York Presbyterian/Columbia College of Physicians and Surgeons, New York, NY

    Linda B. Mongero BS, CCP  & James R. Beck BS, CCP  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Frumento, R.J., Bennett-Guerrero, E. (2008). Prime Solutions for Extracorporeal Circulation. In: Mongero, L.B., Beck, J.R. (eds) On Bypass. Current Cardiac Surgery. Humana Press. https://doi.org/10.1007/978-1-59745-305-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-305-9_4

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-636-8

  • Online ISBN: 978-1-59745-305-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation